At-Home Telemedicine Controlled taVNS Twice Daily for 4 weeks is Feasible and Safe for Long COVID Symptoms.

Guardado en:

Detalles Bibliográficos
Autores principales:	Sarah Huffman, Bashar Badran, Morgan Dancy, Christopher Austelle, Steven Kautz, Mark George
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571
Acceso en línea:	https://doaj.org/article/d44affbb11ca4575ae53614792a52d71
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:d44affbb11ca4575ae53614792a52d71
record_format	dspace
spelling	oai:doaj.org-article:d44affbb11ca4575ae53614792a52d712021-11-20T05:02:39ZAt-Home Telemedicine Controlled taVNS Twice Daily for 4 weeks is Feasible and Safe for Long COVID Symptoms.1935-861X10.1016/j.brs.2021.10.367https://doaj.org/article/d44affbb11ca4575ae53614792a52d712021-11-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S1935861X21006136https://doaj.org/toc/1935-861XSarah HuffmanBashar BadranMorgan DancyChristopher AustelleSteven KautzMark GeorgeElsevierarticleNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571ENBrain Stimulation, Vol 14, Iss 6, Pp 1702-1703 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571
spellingShingle	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Sarah Huffman Bashar Badran Morgan Dancy Christopher Austelle Steven Kautz Mark George At-Home Telemedicine Controlled taVNS Twice Daily for 4 weeks is Feasible and Safe for Long COVID Symptoms.
format	article
author	Sarah Huffman Bashar Badran Morgan Dancy Christopher Austelle Steven Kautz Mark George
author_facet	Sarah Huffman Bashar Badran Morgan Dancy Christopher Austelle Steven Kautz Mark George
author_sort	Sarah Huffman
title	At-Home Telemedicine Controlled taVNS Twice Daily for 4 weeks is Feasible and Safe for Long COVID Symptoms.
title_short	At-Home Telemedicine Controlled taVNS Twice Daily for 4 weeks is Feasible and Safe for Long COVID Symptoms.
title_full	At-Home Telemedicine Controlled taVNS Twice Daily for 4 weeks is Feasible and Safe for Long COVID Symptoms.
title_fullStr	At-Home Telemedicine Controlled taVNS Twice Daily for 4 weeks is Feasible and Safe for Long COVID Symptoms.
title_full_unstemmed	At-Home Telemedicine Controlled taVNS Twice Daily for 4 weeks is Feasible and Safe for Long COVID Symptoms.
title_sort	at-home telemedicine controlled tavns twice daily for 4 weeks is feasible and safe for long covid symptoms.
publisher	Elsevier
publishDate	2021
url	https://doaj.org/article/d44affbb11ca4575ae53614792a52d71
work_keys_str_mv	AT sarahhuffman athometelemedicinecontrolledtavnstwicedailyfor4weeksisfeasibleandsafeforlongcovidsymptoms AT basharbadran athometelemedicinecontrolledtavnstwicedailyfor4weeksisfeasibleandsafeforlongcovidsymptoms AT morgandancy athometelemedicinecontrolledtavnstwicedailyfor4weeksisfeasibleandsafeforlongcovidsymptoms AT christopheraustelle athometelemedicinecontrolledtavnstwicedailyfor4weeksisfeasibleandsafeforlongcovidsymptoms AT stevenkautz athometelemedicinecontrolledtavnstwicedailyfor4weeksisfeasibleandsafeforlongcovidsymptoms AT markgeorge athometelemedicinecontrolledtavnstwicedailyfor4weeksisfeasibleandsafeforlongcovidsymptoms
_version_	1718419688564719616

At-Home Telemedicine Controlled taVNS Twice Daily for 4 weeks is Feasible and Safe for Long COVID Symptoms.

Ejemplares similares